» Articles » PMID: 38727752

Measuring Pelvic Organ Prolapse: An Evolution

Overview
Publisher Springer
Date 2024 May 10
PMID 38727752
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction And Hypothesis: Advances in our understanding of pelvic organ prolapse (POP) have been made with the introduction of valid, reliable measures of anatomy and patient-reported outcome measures.

Methods: This review provides an overview of the evolution of POP measurement and its implications for clinical practice and research.

Results: Since the introduction of the Pelvic Organ Prolapse Quantification (POPQ), studies have demonstrated that some degree of loss of anatomic support is normal, with as many as 40% of normal women having stage 2 prolapse. Vaginal support is dynamic and can wax and wane but is largely stable over time. Vaginal bulge symptoms are the most reliable and specific symptom for POP and the hymen is an important threshold for symptom development. Most pelvic floor symptoms have only weak to moderate correlation with the anatomic severity of POP. Treatment success rates are highly variable depending upon criteria used and definitions of anatomic success commonly used are too strict and often not clinically relevant. There is substantial discordance between subjective and anatomic measures of success, and both are dynamic, fluctuating between success and failure for many patients without intervening treatment.

Conclusions: Pelvic organ prolapse is multidimensional, dynamic, and has a complex impact on patients. Patients' symptoms are more clinically relevant than anatomic support. Symptomatic cure, particularly the absence of vaginal bulge symptoms, is more clinically relevant than anatomic cure and composite outcomes can be misleading and overestimate failure rates. Future studies should compare treatments using continuous variables along multiple dimensions rather than using composite outcomes or dichotomizing patients into success or failure.

Citing Articles

Influence of Transperineal Ultrasound on the POP-Q System in the Surgical Indication of Symptomatic Pelvic Organ Prolapse.

Garcia-Mejido J, Hurtado-Guijosa A, Fernandez-Gomez A, Fernandez-Palacin F, Lao-Pena C, Sainz-Bueno J J Clin Med. 2024; 13(20).

PMID: 39458173 PMC: 11508500. DOI: 10.3390/jcm13206224.


Impact on Sexual Function and Wish for Subsequent Pregnancy after Uterus-Preserving Prolapse Surgery in Premenopausal Women.

Carlin G, Hummel Jimenez J, Lange S, Heinzl F, Koch M, Umek W J Clin Med. 2024; 13(14).

PMID: 39064144 PMC: 11277568. DOI: 10.3390/jcm13144105.

References
1.
Kowalski J, Barber M, Klerkx W, Grzybowska M, Toozs-Hobson P, Rogers R . International urogynecological consultation chapter 4.1: definition of outcomes for pelvic organ prolapse surgery. Int Urogynecol J. 2023; 34(11):2689-2699. DOI: 10.1007/s00192-023-05660-9. View

2.
Swift S, Barber M . Pelvic organ prolapse: defining the disease. Female Pelvic Med Reconstr Surg. 2012; 16(4):201-3. DOI: 10.1097/SPV.0b013e3181f0bf1d. View

3.
Collins S, OShea M, Dykes N, Ramm O, Edenfield A, Shek K . International Urogynecological Consultation: clinical definition of pelvic organ prolapse. Int Urogynecol J. 2021; 32(8):2011-2019. DOI: 10.1007/s00192-021-04875-y. View

4.
Bump R, Mattiasson A, Bo K, Brubaker L, DeLancey J, Klarskov P . The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996; 175(1):10-7. DOI: 10.1016/s0002-9378(96)70243-0. View

5.
Kobak W, Rosenberger K, Walters M . Interobserver variation in the assessment of pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 1996; 7(3):121-4. DOI: 10.1007/BF01894199. View